Rein Therapeutics RNTX
NASDAQ RNTX
$0.80 -0.05 (-6.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Invested Capital (2018 - 2026)

Updated

Rein Therapeutics (RNTX) recorded Invested Capital of $16.51 million in Q1 2026, down 2.4% from the prior quarter.

Analysis

Rein Therapeutics (RNTX) Invested Capital (2018 - 2026) Analysis & Trends

For FY2025, Rein Therapeutics reported Invested Capital of $16.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Rein Therapeutics 57.02 Mn 57.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 16.51 Mn
Dec 31, 2025 16.92 Mn
Dec 31, 2018 24.94 Mn
Sep 30, 2018 31.03 Mn
Jun 30, 2018 36.21 Mn
API Access

Rein Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RNTX&period=max&api_key=YOUR_API_KEY